BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,032.38
0.56%
US Tech 100
20,389.60
0.88%
Dow Jones
44,910.65
0.42%
Brent Oil
71.98
-0.08%
Bitcoin
96,931.87
-0.57%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV

  6. Acasti Pharma Inc (ACST) Quote

Acasti Pharma Inc

Acasti Pharma Inc (ACST)

Acasti Pharma Inc
0.58
0.00
(0.00%)
Closed November 30 4:00PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.58
Bid
0.58
Ask
0.98
Volume
-
0.00 Day's Range 0.00
0.58 52 Week Range 0.58
Market Cap
5.451M
Previous Close
0.58
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
9,399,000
Dividend Yield
-
PE Ratio
-2.46
Earnings Per Share (EPS)
-1.37
Revenue
-
Net Profit
-12.85M

About Acasti Pharma Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.acastipharma.com
Headquarters
Jersey City, New Jersey, USA
Founded
-
Acasti Pharma Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker ACST. The last closing price for Acasti Pharma was $0.58. Over the last year, Acasti Pharma shares have traded in a share price range of $ 0.58 to $ 0.58.

Acasti Pharma currently has 9,399,000 shares outstanding. The market capitalization of Acasti Pharma is $5.45 million. Acasti Pharma has a price to earnings ratio (PE ratio) of -2.46.

Ask ADVFN Intelligence (AI)

ACST Latest News

More News

Acasti Pharma Reports Third Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

February 14 2023
GlobeNewswire Inc.

Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule

LAVAL, Québec, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

January 25 2023
GlobeNewswire Inc.

Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31

LAVAL, Québec, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

January 24 2023
GlobeNewswire Inc.

Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18

LAVAL, Québec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

January 13 2023
GlobeNewswire Inc.

Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures

LAVAL, Québec, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

January 05 2023
GlobeNewswire Inc.

Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia

LAVAL, Québec, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

December 28 2022
GlobeNewswire Inc.

Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN)

LAVAL, Québec, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

December 22 2022
GlobeNewswire Inc.

Acasti Pharma Reports Second Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

November 14 2022
GlobeNewswire Inc.

Acasti Pharma to Present at Q4 Investor Summit

LAVAL, Québec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

November 09 2022
GlobeNewswire Inc.

Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022

LAVAL, Quebec, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical...

November 07 2022
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.580.580.5800CS
4000.580.580.5800CS
12000.580.580.5800CS
26000.580.580.5800CS
52000.580.580.5800CS
156-1.26-68.47826086961.842.30.4739211.50176126CS
260-2.08-78.19548872182.664.050.221079200.89750866CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ENTGEntourage Health Corp
$ 0.015
(200.00%)
2.18M
ACAP.PAtlas One Capital Corporation
$ 0.015
(200.00%)
221.8k
SSESilver Spruce Resources Inc
$ 0.01
(100.00%)
18.01k
XCAP.PExelerate Capital Corp
$ 0.05
(66.67%)
129k
POOLPool Safe Inc
$ 0.04
(60.00%)
158.3k
WWTWater Ways Technologies Inc
$ 0.005
(-50.00%)
52.11k
OSIXOceansix Future Paths Ltd
$ 0.005
(-50.00%)
2.12M
JHCJinhua Capital Corporation
$ 0.005
(-50.00%)
140k
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
130k
MDK.PMDK Acquisition Inc
$ 0.05
(-50.00%)
5k
EGTEguana Technologies Inc
$ 0.01
(0.00%)
2.55M
ENTGEntourage Health Corp
$ 0.015
(200.00%)
2.18M
OSIXOceansix Future Paths Ltd
$ 0.005
(-50.00%)
2.12M
RIORio2 Limited New
$ 0.63
(-4.55%)
2.11M
GBUGabriel Resources Ltd
$ 0.015
(0.00%)
2.02M

Discussion

View Full Feed
RobotDroid RobotDroid 4 minutes ago
Yep. As a long I became increasingly disgruntled with worthless non management going mute and lying to us all. Lied about FDA submission, lied about fast track, and on and on. Soon to be ANOTHER lie by Les about 'Fall'.
NWBO
nowwhat2 nowwhat2 5 minutes ago
How many people own 5000 XRP?
According to the latest data available, there are approximately 10,000 XRP accounts holding between 5000 and 10000 XRP. This represents a small percentage of the total number of XRP accounts in existence.
XRPUSD
melaurian melaurian 5 minutes ago
In answer to your question about bullish and bearish, JMO, but when you look at a bullish stock chart, the stock price will be moving up. This line could also describe the outline of a bull. When the price keeps moving up, the chart could be seen as describing the back, neck, head, and horns of a bu
CGAC
bar1080 bar1080 5 minutes ago
"Bragging about winners one must also admit the losers they own." How often do I have to remind you that I don't have a loss in Boeing which I got as a spinoff from Rockwell International in the late 1990s. I've also said that I tend to ride winners and take my rare losers quickly which is what in
Truthfan Truthfan 5 minutes ago
“We blame Market Makers because they admitted to fraud”

UK….The “Guidance” effective September 1, 2025
https://www.gov.uk/government/news/new-failure-to-prevent-fraud-guidance-published
NWBO
Checkmate 36 Checkmate 36 6 minutes ago
Leg end,

It takes one to know one….so I KNOW you know the definition of fraudulent:

- “obtained, done by, or involving deception, especially criminal deception.”

If I’m not mistaken….MM’s admitted to spoofing sir.

And please oblige, why ar
NWBO
BDEZ BDEZ 6 minutes ago
Felt he had to i'm sure, cause family. That's how politics is..
fuagf fuagf 8 minutes ago
Uh, not according to -- Confirmation: JD Vance is the handpicked leader of the anti-democracy movement in the US

"I think I'd rather deal with vance because he doesn't have shitface's baked in zombie nazi's. vance seemed to gain nothing in his run so if shitface chokes on a chicken n
trader53 trader53 8 minutes ago
WCVC - Designated SURVIVOR !

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174982763


WCVC - Stocks that Returned to Trading After Being Revoked
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174387812

WCVC
Clark6290 Clark6290 9 minutes ago
ROTFLMAO! I have seen a whole lot of ludicrous posts here, but that one is easily in top 3. You must be a renter, section 8?
FNMA
janice shell janice shell 10 minutes ago
You mean for Thanksgiving? Just a stuffed chicken breast. Emphasis, as usual, on the stuffing.
chemist72 chemist72 12 minutes ago
Good to know. Thanks for posting.
GDVM
mascale mascale 12 minutes ago
Published financial statements; OTCIQ verified company profile; Published attorney letter review of financials; and transfer agent verified: That is just OTC. Worldwide consultants creating data, lawfully exported to shareholders. That is public information, like OTC. Toronto rental follows new N
HIRU
Legend431 Legend431 15 minutes ago
When did the mm's admit to fraud?? That is another blatant lie to pump this penny stock!!
NWBO
janice shell janice shell 15 minutes ago
The Wild West returns. Perhaps this is what the penny plungers have been waiting for.

Or is it Gensler's Revenge? He'll be out soon...
BamaBreeze BamaBreeze 17 minutes ago
I hope the reason for that shows itself soon what a "gem" it Is.
BLLB
Johnnycombat10 Johnnycombat10 19 minutes ago
https://www.digital-clarity.com/
DBMM
Johnnycombat10 Johnnycombat10 19 minutes ago
Really nice info at the Digital Clarity, best to look at on laptop or computer.
DBMM
janice shell janice shell 20 minutes ago
I do not doubt what you say.
Mr Smith 34 Mr Smith 34 20 minutes ago
Nate Steck, PPE Solutions Group, LLC , Renavotio, Inc, Kyle Barnette ,Paul D. Strickland, Jr, R & R Goulding, Epidemiologic Solutions Corporation, Mark Thompson, Öztürk Holding, LLC
John Park is either the unluckiest man on the planet at choosing business partners or he has an uncanny knack
SPZI
cowtown jay cowtown jay 20 minutes ago
Placed another sell order for 1200 shares at $4.99, to go along with a previously mentioned existing open sell order, and close out that position if both orders fill.
ChannelTrader ChannelTrader 20 minutes ago
Yep, for sure.
BDEZ BDEZ 20 minutes ago
Nope...

Your Recent History

TSXV
ACST
Acasti Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Small Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2158.56 only $1079.28